Publication | Closed Access

Combined application of plasma mutagenesis and gene engineering leads to 5-oxomilbemycins A3/A4 as main components from Streptomyces bingchenggensis

Gene EngineeringBiosynthesisEngineeringBiotransformationBiochemistryPlasma MutagenesisSynthetic BiologyCombined ApplicationNatural Product BiosynthesisMicrobiologyMolecular MicrobiologyMutagenesis